Comparison of Characteristics of Bacterial Bloodstream Infection between Adult Patients with Allogeneic and Autologous Hematopoietic Stem Cell Transplantation

被引:33
作者
Hong, Junshik [1 ]
Moon, Song Mi [2 ]
Ahn, Hee Kyung [1 ]
Sym, Sun Jin [1 ]
Park, Yoon Soo [2 ]
Park, Jinny [1 ]
Cho, Yong Kyun [2 ]
Cho, Eun Kyung [1 ]
Shin, Dong Bok [1 ]
Lee, Jae Hoon [1 ]
机构
[1] Gachon Univ, Dept Internal Med, Gachon Univ Gil Med Ctr, Div Hematol & Med Oncol,Sch Med, Inchon 405760, South Korea
[2] Gachon Univ, Dept Internal Med, Gachon Univ Gil Med Ctr, Div Infect Dis,Sch Med, Inchon 405760, South Korea
关键词
Bloodstream infection; Bacterial infection; Hematopoietic stem cell transplantation; Antibiotic prophylaxis; C-REACTIVE PROTEIN; NEUTROPENIC PATIENTS; COMORBIDITY INDEX; RISK-ASSESSMENT; SERUM FERRITIN; ACUTE GVHD; RECIPIENTS; PROCALCITONIN; PROPHYLAXIS; PERSPECTIVE;
D O I
10.1016/j.bbmt.2013.03.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although autologous and allogeneic hematopoietic stem cell transplantation (HSCT) are fundamentally different procedures, a tailored approach to bacterial bloodstream infection (BSI) according to the type of HSCT has not yet been suggested. We evaluated the characteristics of BSI after HSCT, with a focus on comparison of BSIs between recipients of autologous HSCT (auto-HSCT) and allogeneic HSCT (allo-HSCT). Among 134 patients (59 received allo-HSCT and 75 received auto-HSCT) who underwent HSCT, BSIs were reported earlier in patients who underwent auto-HSCT, compared with those who underwent allo-HSCT (mean 12.1 +/- 3.4 days versus 32.8 +/- 27.1 days, P = .006). Among patients receiving allo-HSCT, post-neutrophil-engraftment bacterial BSI showed an association with grade >= 2 acute graft-versus-host disease (GVHD). In patients who underwent auto-HSCT, results of multivariate analysis showed that not receiving prophylactic antibiotics (P = .004) and having elevated serum C-reactive protein (P = .034) were risk factors of BSI. Elevated CRP (P = .01) and acute GVHD >= grade 2 (P = .002) were independent risk factors in patients who underwent allo-HSCT. Those differences originated mainly from the impact of acute GVHD-related postengraftment BSIs of patients who underwent allo-HSCT. To establish the best defense strategy against BSI, the distinctive natures of bacterial BSI after HSCT between auto-HSCT and allo-HSCT should be considered. (C) 2013 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:994 / 999
页数:6
相关论文
共 25 条
[1]   Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation [J].
Allan, DS ;
Keeney, M ;
Howson-Jan, K ;
Popma, J ;
Weir, K ;
Bhatia, M ;
Sutherland, DR ;
Chin-Yee, IH .
BONE MARROW TRANSPLANTATION, 2002, 29 (12) :967-972
[2]   Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients [J].
Almyroudis, NG ;
Fuller, A ;
Jakubowski, A ;
Sepkowitz, K ;
Jaffe, D ;
Small, TN ;
Kiehn, TE ;
Pamer, E ;
Papanicolaou, GA .
TRANSPLANT INFECTIOUS DISEASE, 2005, 7 (01) :11-17
[3]   Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course [J].
Avery, R ;
Kalaycio, M ;
Pohlman, B ;
Sobecks, R ;
Kuczkowski, E ;
Andresen, S ;
Mossad, S ;
Shamp, J ;
Curtis, J ;
Kosar, J ;
Sands, K ;
Serafin, M ;
Bolwell, B .
BONE MARROW TRANSPLANTATION, 2005, 35 (05) :497-499
[4]  
Azarpira N, 2009, EXP CLIN TRANSPLANT, V7, P115
[5]   Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients [J].
Dykewicz, CA .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :139-144
[6]   Bacterial infection prevention after hematopoietic cell transplantation [J].
Engelhard, D. ;
Akova, M. ;
Boeckh, M. J. ;
Freifeld, A. ;
Sepkowitz, K. ;
Viscoli, C. ;
Wade, J. ;
Raad, I. .
BONE MARROW TRANSPLANTATION, 2009, 44 (08) :467-470
[7]  
Hamadah A, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0046220
[8]   Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study [J].
Junghanss, C ;
Marr, KA ;
Carter, RA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Chauncey, T ;
McSweeney, PA ;
Storb, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) :512-520
[9]   Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation [J].
Kanda, J. ;
Mizumoto, C. ;
Ichinohe, T. ;
Kawabata, H. ;
Saito, T. ;
Yamashita, K. ;
Kondo, T. ;
Takakura, S. ;
Ichiyama, S. ;
Uchiyama, T. ;
Ishikawa, T. .
BONE MARROW TRANSPLANTATION, 2011, 46 (02) :208-216
[10]   Antibiotic prophylaxis in neutropenic patients - New evidence, practical decisions [J].
Leibovici, Leonard ;
Paul, Mical ;
Cullen, Michael ;
Bucaneve, Giampaolo ;
Gafter-Gvili, Anat ;
Fraser, Abigail ;
Kern, Winfried V. .
CANCER, 2006, 107 (08) :1743-1751